The global Medical Nicotine Transdermal Skin Patch market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
21 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Nicotine Transdermal Skin Patch include Habitrol, Nicotrol, Nicoderm, Aroamas Cot, Hisamitsu Pharmaceutica, Novartis, Johnson & Johnson, Teikoku Pharma and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Nicotine Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Nicotine Transdermal Skin Patch. This report contains market size and forecasts of Medical Nicotine Transdermal Skin Patch in global, including the following market information:
Global Medical Nicotine Transdermal Skin Patch Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Nicotine Transdermal Skin Patch Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Medical Nicotine Transdermal Skin Patch companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Nicotine Transdermal Skin Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Nicotine Transdermal Skin Patch Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Nicotine Transdermal Skin Patch Market Segment Percentages, by Type, 2022 (%)
21 mg
14 mg
7 mg
Global Medical Nicotine Transdermal Skin Patch Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Nicotine Transdermal Skin Patch Market Segment Percentages, by Application, 2022 (%)
Smoking Cessation Centres
Hospitals
Home
Others
Global Medical Nicotine Transdermal Skin Patch Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Nicotine Transdermal Skin Patch Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Nicotine Transdermal Skin Patch revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Nicotine Transdermal Skin Patch revenues share in global market, 2022 (%)
Key companies Medical Nicotine Transdermal Skin Patch sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Nicotine Transdermal Skin Patch sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Habitrol
Nicotrol
Nicoderm
Aroamas Cot
Hisamitsu Pharmaceutica
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Nicotine Transdermal Skin Patch, market overview.
Chapter 2: Global Medical Nicotine Transdermal Skin Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Nicotine Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Nicotine Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Nicotine Transdermal Skin Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Medical Nicotine Transdermal Skin Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Nicotine Transdermal Skin Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Nicotine Transdermal Skin Patch Overall Market Size
2.1 Global Medical Nicotine Transdermal Skin Patch Market Size: 2022 VS 2029
2.2 Global Medical Nicotine Transdermal Skin Patch Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Nicotine Transdermal Skin Patch Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Nicotine Transdermal Skin Patch Players in Global Market
3.2 Top Global Medical Nicotine Transdermal Skin Patch Companies Ranked by Revenue
3.3 Global Medical Nicotine Transdermal Skin Patch Revenue by Companies
3.4 Global Medical Nicotine Transdermal Skin Patch Sales by Companies
3.5 Global Medical Nicotine Transdermal Skin Patch Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Nicotine Transdermal Skin Patch Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Nicotine Transdermal Skin Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Nicotine Transdermal Skin Patch Players in Global Market
3.8.1 List of Global Tier 1 Medical Nicotine Transdermal Skin Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Nicotine Transdermal Skin Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Medical Nicotine Transdermal Skin Patch Market Size Markets, 2022 & 2029
4.1.2 21 mg
4.1.3 14 mg
4.1.4 7 mg
4.2 By Type - Global Medical Nicotine Transdermal Skin Patch Revenue & Forecasts
4.2.1 By Type - Global Medical Nicotine Transdermal Skin Patch Revenue, 2018-2023
4.2.2 By Type - Global Medical Nicotine Transdermal Skin Patch Revenue, 2024-2029
4.2.3 By Type - Global Medical Nicotine Transdermal Skin Patch Revenue Market Share, 2018-2029
4.3 By Type - Global Medical Nicotine Transdermal Skin Patch Sales & Forecasts
4.3.1 By Type - Global Medical Nicotine Transdermal Skin Patch Sales, 2018-2023
4.3.2 By Type - Global Medical Nicotine Transdermal Skin Patch Sales, 2024-2029
4.3.3 By Type - Global Medical Nicotine Transdermal Skin Patch Sales Market Share, 2018-2029
4.4 By Type - Global Medical Nicotine Transdermal Skin Patch Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Medical Nicotine Transdermal Skin Patch Market Size, 2022 & 2029
5.1.2 Smoking Cessation Centres
5.1.3 Hospitals
5.1.4 Home
5.1.5 Others
5.2 By Application - Global Medical Nicotine Transdermal Skin Patch Revenue & Forecasts
5.2.1 By Application - Global Medical Nicotine Transdermal Skin Patch Revenue, 2018-2023
5.2.2 By Application - Global Medical Nicotine Transdermal Skin Patch Revenue, 2024-2029
5.2.3 By Application - Global Medical Nicotine Transdermal Skin Patch Revenue Market Share, 2018-2029
5.3 By Application - Global Medical Nicotine Transdermal Skin Patch Sales & Forecasts
5.3.1 By Application - Global Medical Nicotine Transdermal Skin Patch Sales, 2018-2023
5.3.2 By Application - Global Medical Nicotine Transdermal Skin Patch Sales, 2024-2029
5.3.3 By Application - Global Medical Nicotine Transdermal Skin Patch Sales Market Share, 2018-2029
5.4 By Application - Global Medical Nicotine Transdermal Skin Patch Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Medical Nicotine Transdermal Skin Patch Market Size, 2022 & 2029
6.2 By Region - Global Medical Nicotine Transdermal Skin Patch Revenue & Forecasts
6.2.1 By Region - Global Medical Nicotine Transdermal Skin Patch Revenue, 2018-2023
6.2.2 By Region - Global Medical Nicotine Transdermal Skin Patch Revenue, 2024-2029
6.2.3 By Region - Global Medical Nicotine Transdermal Skin Patch Revenue Market Share, 2018-2029
6.3 By Region - Global Medical Nicotine Transdermal Skin Patch Sales & Forecasts
6.3.1 By Region - Global Medical Nicotine Transdermal Skin Patch Sales, 2018-2023
6.3.2 By Region - Global Medical Nicotine Transdermal Skin Patch Sales, 2024-2029
6.3.3 By Region - Global Medical Nicotine Transdermal Skin Patch Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Medical Nicotine Transdermal Skin Patch Revenue, 2018-2029
6.4.2 By Country - North America Medical Nicotine Transdermal Skin Patch Sales, 2018-2029
6.4.3 US Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.4.4 Canada Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.4.5 Mexico Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Medical Nicotine Transdermal Skin Patch Revenue, 2018-2029
6.5.2 By Country - Europe Medical Nicotine Transdermal Skin Patch Sales, 2018-2029
6.5.3 Germany Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.4 France Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.5 U.K. Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.6 Italy Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.7 Russia Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.8 Nordic Countries Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.5.9 Benelux Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Medical Nicotine Transdermal Skin Patch Revenue, 2018-2029
6.6.2 By Region - Asia Medical Nicotine Transdermal Skin Patch Sales, 2018-2029
6.6.3 China Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.6.4 Japan Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.6.5 South Korea Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.6.6 Southeast Asia Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.6.7 India Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Medical Nicotine Transdermal Skin Patch Revenue, 2018-2029
6.7.2 By Country - South America Medical Nicotine Transdermal Skin Patch Sales, 2018-2029
6.7.3 Brazil Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.7.4 Argentina Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Medical Nicotine Transdermal Skin Patch Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Medical Nicotine Transdermal Skin Patch Sales, 2018-2029
6.8.3 Turkey Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.8.4 Israel Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
6.8.6 UAE Medical Nicotine Transdermal Skin Patch Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Habitrol
7.1.1 Habitrol Company Summary
7.1.2 Habitrol Business Overview
7.1.3 Habitrol Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.1.4 Habitrol Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.1.5 Habitrol Key News & Latest Developments
7.2 Nicotrol
7.2.1 Nicotrol Company Summary
7.2.2 Nicotrol Business Overview
7.2.3 Nicotrol Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.2.4 Nicotrol Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.2.5 Nicotrol Key News & Latest Developments
7.3 Nicoderm
7.3.1 Nicoderm Company Summary
7.3.2 Nicoderm Business Overview
7.3.3 Nicoderm Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.3.4 Nicoderm Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.3.5 Nicoderm Key News & Latest Developments
7.4 Aroamas Cot
7.4.1 Aroamas Cot Company Summary
7.4.2 Aroamas Cot Business Overview
7.4.3 Aroamas Cot Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.4.4 Aroamas Cot Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.4.5 Aroamas Cot Key News & Latest Developments
7.5 Hisamitsu Pharmaceutica
7.5.1 Hisamitsu Pharmaceutica Company Summary
7.5.2 Hisamitsu Pharmaceutica Business Overview
7.5.3 Hisamitsu Pharmaceutica Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.5.4 Hisamitsu Pharmaceutica Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.5.5 Hisamitsu Pharmaceutica Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.6.4 Novartis Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.7.4 Johnson & Johnson Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Teikoku Pharma
7.8.1 Teikoku Pharma Company Summary
7.8.2 Teikoku Pharma Business Overview
7.8.3 Teikoku Pharma Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.8.4 Teikoku Pharma Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.8.5 Teikoku Pharma Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.9.4 Mylan Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Actavis
7.10.1 Actavis Company Summary
7.10.2 Actavis Business Overview
7.10.3 Actavis Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.10.4 Actavis Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.10.5 Actavis Key News & Latest Developments
7.11 Mundipharma
7.11.1 Mundipharma Company Summary
7.11.2 Mundipharma Medical Nicotine Transdermal Skin Patch Business Overview
7.11.3 Mundipharma Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.11.4 Mundipharma Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.11.5 Mundipharma Key News & Latest Developments
7.12 Henan Lingrui pharmaceutical
7.12.1 Henan Lingrui pharmaceutical Company Summary
7.12.2 Henan Lingrui pharmaceutical Medical Nicotine Transdermal Skin Patch Business Overview
7.12.3 Henan Lingrui pharmaceutical Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.12.4 Henan Lingrui pharmaceutical Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.12.5 Henan Lingrui pharmaceutical Key News & Latest Developments
7.13 Changzhou Siyao
7.13.1 Changzhou Siyao Company Summary
7.13.2 Changzhou Siyao Medical Nicotine Transdermal Skin Patch Business Overview
7.13.3 Changzhou Siyao Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.13.4 Changzhou Siyao Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.13.5 Changzhou Siyao Key News & Latest Developments
7.14 Rfl Pharmaceutical
7.14.1 Rfl Pharmaceutical Company Summary
7.14.2 Rfl Pharmaceutical Business Overview
7.14.3 Rfl Pharmaceutical Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.14.4 Rfl Pharmaceutical Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.14.5 Rfl Pharmaceutical Key News & Latest Developments
7.15 Luye Pharma Group Ltd.
7.15.1 Luye Pharma Group Ltd. Company Summary
7.15.2 Luye Pharma Group Ltd. Business Overview
7.15.3 Luye Pharma Group Ltd. Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.15.4 Luye Pharma Group Ltd. Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.15.5 Luye Pharma Group Ltd. Key News & Latest Developments
7.16 Purdue Pharma L.P
7.16.1 Purdue Pharma L.P Company Summary
7.16.2 Purdue Pharma L.P Business Overview
7.16.3 Purdue Pharma L.P Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.16.4 Purdue Pharma L.P Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.16.5 Purdue Pharma L.P Key News & Latest Developments
7.17 Teva Pharmaceutical Industries
7.17.1 Teva Pharmaceutical Industries Company Summary
7.17.2 Teva Pharmaceutical Industries Business Overview
7.17.3 Teva Pharmaceutical Industries Medical Nicotine Transdermal Skin Patch Major Product Offerings
7.17.4 Teva Pharmaceutical Industries Medical Nicotine Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.17.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Medical Nicotine Transdermal Skin Patch Production Capacity, Analysis
8.1 Global Medical Nicotine Transdermal Skin Patch Production Capacity, 2018-2029
8.2 Medical Nicotine Transdermal Skin Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Nicotine Transdermal Skin Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Nicotine Transdermal Skin Patch Supply Chain Analysis
10.1 Medical Nicotine Transdermal Skin Patch Industry Value Chain
10.2 Medical Nicotine Transdermal Skin Patch Upstream Market
10.3 Medical Nicotine Transdermal Skin Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Nicotine Transdermal Skin Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report